You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

PAMINE FORTE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pamine Forte patents expire, and when can generic versions of Pamine Forte launch?

Pamine Forte is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE FORTE is methscopolamine bromide. There are seven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pamine Forte

A generic version of PAMINE FORTE was approved as methscopolamine bromide by BRECKENRIDGE PHARM on December 6th, 2011.

  Try a Trial

US Patents and Regulatory Information for PAMINE FORTE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.